Robert John Andrew Ryan Acquires 9,500 Shares of ASP Isotopes Inc. (NASDAQ:ASPI) Stock

ASP Isotopes Inc. (NASDAQ:ASPI - Get Free Report) Director Robert John Andrew Ryan acquired 9,500 shares of ASP Isotopes stock in a transaction that occurred on Thursday, April 25th. The shares were purchased at an average price of $3.42 per share, for a total transaction of $32,490.00. Following the completion of the purchase, the director now directly owns 546,555 shares of the company's stock, valued at $1,869,218.10. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink.

ASP Isotopes Stock Performance

Shares of NASDAQ ASPI opened at $3.21 on Tuesday. The company has a quick ratio of 1.85, a current ratio of 1.85 and a debt-to-equity ratio of 0.01. The firm's 50-day moving average price is $3.72 and its two-hundred day moving average price is $2.52. ASP Isotopes Inc. has a 52-week low of $0.28 and a 52-week high of $4.97. The stock has a market capitalization of $157.03 million, a P/E ratio of -6.55 and a beta of 5.04.

ASP Isotopes (NASDAQ:ASPI - Get Free Report) last announced its quarterly earnings results on Wednesday, April 10th. The company reported ($0.09) earnings per share (EPS) for the quarter. The company had revenue of $0.43 million during the quarter. As a group, sell-side analysts forecast that ASP Isotopes Inc. will post -0.11 earnings per share for the current year.

Analysts Set New Price Targets


The most important AI company you've never heard of
Because this small company solves the BIGGEST problem with Nvidia's AI chips. Already, Amazon, Microsoft, Google and others are lining up to get this company's products.
Get the full story on this secret AI company poised for massive growth


Separately, HC Wainwright increased their target price on shares of ASP Isotopes from $5.25 to $5.50 and gave the stock a "buy" rating in a report on Wednesday, April 17th.

Check Out Our Latest Analysis on ASP Isotopes

Institutional Investors Weigh In On ASP Isotopes

A hedge fund recently bought a new stake in ASP Isotopes stock. HTLF Bank acquired a new position in ASP Isotopes Inc. (NASDAQ:ASPI - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 78,538 shares of the company's stock, valued at approximately $141,000. HTLF Bank owned 0.16% of ASP Isotopes as of its most recent SEC filing. 16.80% of the stock is owned by institutional investors.

ASP Isotopes Company Profile

(Get Free Report)

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.

Read More

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [email protected].

Insider Buying or Selling at ASP Isotopes?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for ASP Isotopes and related companies.
Free Insider Buying and Selling Newsletter
Enter your email address below to receive InsiderTrades.com's daily insider buying and selling report.

Most Read This Month

Recent Articles